YKL202W Antibody

Shipped with Ice Packs
In Stock

Description

Introduction

The YKL202W Antibody is a custom-produced monoclonal antibody developed for research applications, primarily targeting proteins associated with Saccharomyces cerevisiae (Baker's yeast) . Antibodies like YKL202W are integral to immunological research, enabling the detection and characterization of specific antigens in biological systems. Structurally, antibodies are Y-shaped glycoproteins composed of heavy and light chains, with variable regions (paratopes) that bind to epitopes on target antigens . Their versatility in assays such as Western blotting, immunohistochemistry, and ELISA makes them critical tools in molecular biology.

Target and Reactivity

The YKL202W Antibody is engineered to recognize proteins expressed in S. cerevisiae strain ATCC 204508/S288c . While specific antigen details are not fully disclosed in the available literature, yeast proteins often serve as models for studying eukaryotic cellular processes, such as metabolic regulation, stress response, or protein folding. The antibody’s reactivity is validated in assays mimicking conditions used in yeast biology research, including fixed and permeabilized cell samples .

PropertyDetails
Target OrganismSaccharomyces cerevisiae (strain ATCC 204508/S288c)
Antigen ClassYeast-specific protein (exact identity not specified)
ApplicationImmunohistochemistry, Western blot, ELISA
FormatMonoclonal antibody (customizable)
SourceMammalian expression system (e.g., CHO cells)

Applications

The YKL202W Antibody is likely used in:

  • Protein localization studies in yeast models to map subcellular distribution.

  • Western blotting for quantifying protein expression levels under varying conditions.

  • Immunoprecipitation to isolate protein complexes for downstream analysis .

Its specificity for yeast antigens aligns with broader trends in antibody characterization, where reagents must be rigorously validated to avoid cross-reactivity . For example, initiatives like YCharOS emphasize the importance of knockout (KO) cell line testing to ensure antibody specificity .

Validation and Challenges

While the antibody’s manufacturer (Cusabio) reports validation in yeast assays , independent verification is limited. Common challenges in antibody development include:

  • Cross-reactivity with homologous proteins in other organisms.

  • Lot-to-lot variability, particularly in polyclonal antibodies .

  • Limited availability of KO yeast strains for comprehensive specificity testing .

Validation MethodOutcome
ELISAPositive binding to recombinant antigen
ImmunohistochemistrySpecific staining in permeabilized yeast cells
Western BlotBand detection at expected molecular weight

Research Context

YKL202W’s role in yeast biology research is part of a broader antibody ecosystem. Studies on SARS-CoV-2 antibodies highlight the importance of structural mapping and epitope clustering , principles that could inform future optimizations for YKL202W. Similarly, collaborations between academic labs and industry partners (e.g., NeuroMab) underscore the value of standardized protocols in antibody development.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YKL202W antibody; Putative uncharacterized protein YKL202W antibody
Target Names
YKL202W
Uniprot No.

Q&A

What is YKL202W and what role do antibodies play in studying this protein?

YKL202W is a yeast gene encoding a protein involved in cellular signaling pathways. Similar to other yeast proteins like Ycx1 (encoded by YDL206W), it likely plays a specific role in yeast cell biology that can be studied using antibody-based techniques. Antibodies against YKL202W enable researchers to detect, quantify, and visualize this protein in various experimental contexts.

Antibodies against yeast proteins typically recognize specific epitopes and can be used to determine protein expression levels, subcellular localization, and protein-protein interactions. When studying yeast proteins like YKL202W, researchers should consider that these proteins often have specialized functions within cellular compartments, similar to how YDL206W localizes to the endoplasmic reticulum and Golgi apparatus and influences calcium signaling pathways .

What antibody validation strategies are essential before using YKL202W antibodies?

Binary validation approaches represent one of the most effective strategies for evaluating antibody specificity before experimental use. This involves testing the antibody in both positive and negative expression systems to confirm target recognition without cross-reactivity.

For YKL202W antibodies, validation should include:

  • Endogenous controls: Testing in yeast strains known to express or lack YKL202W

  • Genetic knockouts: Comparing antibody signal between wild-type and YKL202W deletion strains

  • Western blot validation: Confirming single-band specificity at the expected molecular weight

  • Cross-application validation: Verifying specificity across different applications (WB, IHC, IF)

As illustrated in antibody validation literature, each model used for binary validation should be tested in every intended application, as specificity in one application (e.g., Western blot) does not guarantee specificity in another (e.g., immunohistochemistry) .

What are the optimal experimental conditions for Western blot with YKL202W antibodies?

For optimal Western blot results with YKL202W antibodies, consider the following methodological approach:

  • Sample preparation: Prepare yeast lysates using glass bead disruption in buffer containing protease inhibitors

  • Protein loading: Load 20-50 μg of total protein per lane, with β-actin as loading control

  • Gel selection: Use 10-12% SDS-PAGE gels for optimal resolution of YKL202W

  • Transfer conditions: Transfer to PVDF membrane at 100V for 1 hour or 30V overnight

  • Blocking: Block with 5% non-fat milk in TBST for 1 hour at room temperature

  • Primary antibody: Optimize dilution (typically 1:1000 to 1:5000) in blocking buffer; incubate overnight at 4°C

  • Controls: Include positive controls (expressing YKL202W) and negative controls (deletion strains)

Researchers should validate antibody specificity by checking for a single band at the expected molecular weight, similar to the binary testing approach shown for other antibodies in Figure 1 of standard validation protocols, where specific antibodies demonstrate clear discrimination between positive and negative cell lines .

How can I determine the appropriate antibody concentration for immunohistochemistry?

Determining optimal antibody concentration for immunohistochemistry requires systematic titration:

  • Initial range finding: Test 3-4 dilutions spanning a wide range (e.g., 1:100, 1:500, 1:1000, 1:5000)

  • Fine-tuning: Narrow the dilution range based on initial results

  • Control inclusion: Always include positive and negative controls in each experiment

  • Evaluation criteria:

    • Signal-to-noise ratio

    • Specific staining pattern

    • Background minimization

    • Reproducibility

Follow a similar approach to that shown in Figure 2 of standard IHC validation protocols, where positive cell pellets (expressing the target protein) show strong staining while negative cell pellets show minimal background, confirming specificity of the antibody .

How can YKL202W antibodies be used to investigate protein-protein interactions?

YKL202W antibodies can be powerful tools for investigating protein-protein interactions through several methodological approaches:

  • Co-immunoprecipitation (Co-IP):

    • Lyse yeast cells under non-denaturing conditions

    • Incubate lysate with YKL202W antibody conjugated to protein A/G beads

    • Wash complexes and elute

    • Analyze interacting partners by mass spectrometry or Western blot

  • Proximity Ligation Assay (PLA):

    • Fix yeast cells and permeabilize

    • Incubate with YKL202W antibody and antibody against potential interacting partner

    • Add PLA probes, ligase, and polymerase

    • Visualize interaction signals by fluorescence microscopy

  • Pull-down assays with recombinant proteins:

    • Express tagged YKL202W in bacterial or yeast systems

    • Immobilize purified protein on appropriate matrix

    • Incubate with cell lysates

    • Identify binding partners using YKL202W antibodies for confirmation

This approach parallels methods used to study signaling pathway components in yeast, such as those employed to characterize the Ycx1 protein's role in calcium and calcineurin signaling .

What strategies can address cross-reactivity issues with YKL202W antibodies?

Addressing cross-reactivity requires a multi-faceted approach:

  • Epitope mapping:

    • Identify the specific region recognized by the antibody

    • Compare with homologous proteins to predict potential cross-reactivity

    • Use peptide competition assays to confirm epitope specificity

  • Pre-adsorption controls:

    • Pre-incubate antibody with purified YKL202W protein

    • Compare signal between pre-adsorbed and non-adsorbed antibody

    • Reduction in signal indicates specificity

  • Multiple antibody validation:

    • Use antibodies targeting different epitopes of YKL202W

    • Compare signal patterns across experiments

    • Consistent results with different antibodies increase confidence

  • Genetic control experiments:

    • Test antibody in YKL202W knockout strains

    • Complete absence of signal confirms specificity

These approaches parallel binary validation strategies described in antibody validation literature, where endogenous controls with variable expression levels provide confidence in specificity .

How can YKL202W antibodies be used to study protein localization changes during stress responses?

Studying YKL202W localization during stress requires careful experimental design:

  • Time-course experiments:

    • Subject yeast cells to relevant stressors (oxidative stress, heat shock, nutrient deprivation)

    • Fix cells at defined time points (0, 15, 30, 60 min, etc.)

    • Perform immunofluorescence with YKL202W antibodies

    • Co-stain with organelle markers (nuclear, ER, Golgi, mitochondrial)

  • Live-cell imaging:

    • Create strains expressing fluorescent protein-tagged YKL202W

    • Validate tag function using YKL202W antibodies

    • Perform time-lapse microscopy during stress application

    • Analyze dynamics of localization changes

  • Biochemical fractionation:

    • Separate cellular compartments (cytosol, nucleus, organelles)

    • Analyze YKL202W distribution by Western blot

    • Quantify changes in distribution ratios

This parallels approaches used to determine subcellular localization of yeast proteins like YDL206W, which was found to localize to the endoplasmic reticulum and Golgi through subcellular localization studies .

What advanced techniques can quantify YKL202W phosphorylation states using phospho-specific antibodies?

To study YKL202W phosphorylation states:

  • Phospho-specific antibody development:

    • Generate antibodies against predicted phosphorylation sites

    • Validate using phosphatase treatments as negative controls

    • Confirm with kinase assays as positive controls

  • Quantitative phosphoproteomics:

    • Immunoprecipitate YKL202W using total protein antibodies

    • Analyze phosphorylation by mass spectrometry

    • Use phospho-specific antibodies to confirm sites

  • Multiplexed detection methods:

    • Implement multiplexed Western blotting with total and phospho-antibodies

    • Use fluorescent secondary antibodies for simultaneous detection

    • Quantify phosphorylation/total protein ratios

  • In-cell validation:

    • Apply treatments affecting relevant kinase/phosphatase pathways

    • Monitor changes in phosphorylation using phospho-specific antibodies

    • Correlate with functional assays

This approach is similar to target antigen modification validation methods that involve using treatments to induce or inhibit post-translational modifications of protein targets, as described in antibody validation literature .

What is the recommended protocol for optimizing immunoprecipitation with YKL202W antibodies?

Optimizing immunoprecipitation with YKL202W antibodies requires systematic protocol refinement:

  • Antibody amount optimization:

    • Test a range (1-10 μg) of antibody per reaction

    • Determine minimum amount needed for efficient target capture

  • Lysate preparation optimization:

    • Test different lysis buffers (varying detergents and salt concentrations)

    • Optimize cell disruption methods for yeast cells (glass beads, enzymatic digestion)

    • Include appropriate protease/phosphatase inhibitors

  • Binding conditions optimization:

    • Compare different incubation times (1 hour vs. overnight)

    • Test various temperatures (4°C vs. room temperature)

    • Evaluate different binding matrices (protein A/G, magnetic vs. agarose)

  • Wash stringency balance:

    • Develop a washing protocol that removes non-specific interactions

    • Maintain specific interactions by optimizing detergent and salt concentrations

    • Consider including competitors for common non-specific interactions

  • Elution method selection:

    • Compare different elution methods (low pH, antigenic peptide, SDS)

    • Select method appropriate for downstream applications

This systematic approach parallels binary validation strategies where experimental conditions are carefully optimized to ensure specificity and sensitivity .

How can I troubleshoot weak or absent signals when using YKL202W antibodies?

When encountering weak or absent signals, implement this troubleshooting workflow:

ProblemPotential CausesSolutions
No signalProtein expression too lowUse enrichment techniques before detection
Antibody concentration insufficientIncrease antibody concentration
Epitope masked/destroyedTry different extraction methods
Detection system insensitiveSwitch to more sensitive detection method
Weak signalInsufficient antibodyIncrease concentration or incubation time
Inefficient protein transferOptimize transfer conditions
Poor sample preparationImprove lysis protocol, add protease inhibitors
Suboptimal blockingTest alternative blocking reagents
High backgroundExcessive antibodyDilute antibody further
Insufficient washingIncrease wash duration and frequency
Non-specific bindingAdd blocking proteins to antibody diluent
Cross-reactivityTry more specific antibody or pre-adsorption

This troubleshooting approach draws on principles established in the binary validation strategy, which emphasizes the importance of appropriate positive and negative controls to ensure reliable results .

What are the recommended controls for immunofluorescence microscopy with YKL202W antibodies?

Comprehensive controls for immunofluorescence microscopy should include:

  • Primary antibody controls:

    • Omission control: no primary antibody to assess secondary antibody specificity

    • Isotype control: irrelevant primary antibody of same isotype

    • Concentration-matched pre-immune serum for polyclonal antibodies

  • Genetic controls:

    • YKL202W deletion strains as negative controls

    • YKL202W overexpression strains as positive controls

    • Tagged YKL202W strains for co-localization validation

  • Signal specificity controls:

    • Peptide competition: pre-incubate antibody with purified antigen

    • Antibody dilution series to demonstrate dose-dependent signal

    • Multiple antibodies targeting different epitopes

  • Subcellular marker controls:

    • Co-staining with established organelle markers

    • Correlation with GFP-tagged protein localization

    • Comparison with published localization data

This parallels the approach shown in Figures 1 and 2 of standard validation protocols, where antibodies are validated across multiple applications using appropriate positive and negative controls .

How should I design experiments to measure YKL202W protein-protein interactions in different genetic backgrounds?

When designing experiments to study YKL202W interactions across genetic backgrounds:

  • Experimental design framework:

    • Select appropriate yeast strains (wild-type, mutants affecting pathways of interest)

    • Ensure consistent culture conditions across all strains

    • Process all samples in parallel to minimize technical variation

  • Interaction detection methods:

    • Co-immunoprecipitation with YKL202W antibodies

    • Bimolecular fluorescence complementation (BiFC)

    • Förster resonance energy transfer (FRET)

    • Yeast two-hybrid screening with YKL202W as bait

  • Quantification approaches:

    • Quantitative Western blotting for co-IP samples

    • Fluorescence intensity measurements for BiFC/FRET

    • Statistical analysis to determine significance of differences

  • Validation strategy:

    • Confirm key interactions by multiple methods

    • Perform reverse co-IP with antibodies against interacting partners

    • Validate functional relevance through phenotypic analysis of interaction mutants

This experimental design strategy parallels approaches used to study protein functions in yeast signaling pathways, such as those employed to characterize Ycx1's role in calcium signaling networks .

What statistical methods are appropriate for analyzing Western blot data from YKL202W antibody experiments?

When analyzing Western blot data from YKL202W antibody experiments, implement these statistical approaches:

  • Quantification procedure:

    • Use specialized software (ImageJ, Image Lab, etc.) for densitometry

    • Normalize target protein bands to loading controls (β-actin, GAPDH)

    • Express results as relative band intensity

  • Statistical testing:

    • For two-group comparisons: Student's t-test or Mann-Whitney U test

    • For multiple groups: ANOVA with appropriate post-hoc tests

    • For time-course experiments: repeated measures ANOVA

  • Technical considerations:

    • Perform experiments in biological triplicates (minimum)

    • Test for normal distribution before selecting parametric/non-parametric tests

    • Report both effect size and p-values

  • Visualization methods:

    • Bar graphs showing mean ± standard deviation/SEM

    • Include individual data points to show distribution

    • Present representative blot images alongside quantification

This analytical approach aligns with the ranged validation strategy, where multiple samples with varying expression levels are quantitatively compared to establish antibody reliability across a spectrum of target concentrations .

How can multiple antibody-based techniques be integrated to build a comprehensive understanding of YKL202W function?

Integrating multiple antibody-based techniques requires a strategic methodological approach:

  • Complementary technique selection:

    • Western blot: quantitative expression analysis

    • Immunoprecipitation: protein interaction studies

    • Immunofluorescence: subcellular localization

    • ChIP: DNA binding and transcriptional regulation (if applicable)

  • Data integration framework:

    • Create standardized experimental conditions across techniques

    • Develop consistent data normalization methods

    • Implement cross-validation between techniques

  • Functional correlation analysis:

    • Compare protein expression (Western blot) with localization patterns

    • Correlate interaction partners (co-IP) with functional pathways

    • Link post-translational modifications to subcellular distribution

  • Systems biology approach:

    • Incorporate antibody-derived data into interaction networks

    • Develop predictive models of YKL202W function

    • Test model predictions with targeted experiments

This integrated approach parallels comprehensive antibody validation strategies that employ multiple testing methods to build confidence in antibody specificity and performance across different applications .

How can YKL202W antibodies be used in high-throughput screening applications?

Utilizing YKL202W antibodies for high-throughput screening requires specialized methodological considerations:

  • Assay development:

    • Adapt antibody-based detection to microplate format

    • Optimize primary and secondary antibody concentrations

    • Develop appropriate positive and negative controls

    • Establish Z-factor to validate assay robustness

  • Screening approaches:

    • ELISA-based detection for quantitative measurement

    • Automated immunofluorescence for localization studies

    • Protein array applications for interaction screening

  • Automation considerations:

    • Liquid handling optimization for antibody dispensing

    • Incubation time and temperature standardization

    • Washing protocol development for consistent background reduction

  • Data analysis pipeline:

    • Implement automated image analysis algorithms

    • Develop statistical criteria for hit identification

    • Establish secondary validation protocols for primary hits

This high-throughput approach builds upon established antibody validation methods, extending them to large-scale applications while maintaining the specificity and reliability principles demonstrated in binary and ranged validation strategies .

What approaches can determine post-translational modifications of YKL202W using specialized antibodies?

Investigating post-translational modifications (PTMs) of YKL202W requires specialized antibody applications:

  • PTM-specific antibody selection:

    • Phospho-specific antibodies for kinase pathway studies

    • Ubiquitin-specific antibodies for degradation studies

    • Acetylation/methylation antibodies for epigenetic regulation

  • Validation of PTM-specific antibodies:

    • Test specificity using enzymes that add/remove modifications

    • Compare wild-type to mutant proteins lacking modification sites

    • Perform peptide competition with modified and unmodified peptides

  • Experimental approaches:

    • Western blot with PTM-specific antibodies

    • Immunoprecipitation with total protein antibody followed by PTM detection

    • Mass spectrometry validation of detected modifications

  • Functional correlation:

    • Compare PTM status across different growth conditions

    • Analyze PTM changes during cell cycle or stress responses

    • Correlate PTM status with protein activity or localization

This specialized approach parallels target antigen modification validation methods described in antibody validation literature, where treatments to induce or inhibit post-translational modifications are used to validate antibody specificity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.